The genetic determinants of renal impairment following cardiac surgery

Robert B Yates1, Mark Stafford-Smith

  • 1Department of Anesthesiology, Duke University Medical Center, Durham, NC 27710, USA.

Insights

Genetic factors influence kidney injury after cardiac surgery. Understanding these genetic variations is crucial for identifying at-risk patients and developing new treatments for post-cardiac surgery renal dysfunction.

Area of Science:

  • Nephrology
  • Cardiology
  • Genetics

Background:

  • Acute kidney dysfunction is a frequent complication after cardiac surgery, leading to increased morbidity, mortality, and hospital stays.
  • Current understanding of cardiac surgery-related renal injury mechanisms and effective prevention/treatment strategies remains limited.
  • Identifying at-risk patients for renal dysfunction post-cardiac surgery is challenging due to a lack of predictive paradigms.

Purpose of the Study:

  • To review the current literature on genetic polymorphisms associated with post-cardiac surgery renal dysfunction.
  • To highlight the role of genetic variability in understanding the pathophysiology of renal injury following cardiac surgery.
  • To emphasize the potential of genetic approaches in elucidating molecular mechanisms and informing future therapeutic strategies.

Main Methods:

  • Literature review focusing on studies investigating genetic polymorphisms and their association with renal dysfunction after cardiac surgery.
  • Analysis of current research on the physiological and pathophysiological systems underlying renal dysfunction in this context.
  • Synthesis of findings related to genetic variability and its impact on post-operative kidney outcomes.

Main Results:

  • Genetic variability plays a significant role in the development of renal dysfunction following cardiac surgery.
  • Specific genetic polymorphisms are being investigated for their potential to predict patient susceptibility to kidney injury.
  • Research is increasingly focusing on genetic factors to unravel the complex mechanisms of cardiac surgery-associated kidney disease.

Conclusions:

  • Genetic polymorphisms are critical factors in post-cardiac surgery renal dysfunction.
  • Further research into genetic variability is essential for developing targeted therapies and improving patient outcomes.
  • Understanding the genetic basis of renal injury can lead to better risk stratification and personalized treatment approaches.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...